Tyrosine Kinase
Receptor tyrosine kinases bind to extracellular ligands/growth factors, which promotes receptor dimerization and autophosphorylation of receptor tyrosine residues. This triggers a cascade of downstream events through phosphorylation of intracellular proteins that ultimately transduce the extracellular signal to the nucleus, causing changes in gene expression. Receptor tyrosine kinases include EGFR/ErbB, PDGFR, VEGFR, FGFR and MET subfamilies etc. Dysfunctions in tyrosine phosphorylation are linked to oncogenic transformation. In additions, various adaptor and effector proteins couple to carboxy-terminal of an active kinase. For instance, binding of the GRB2 adaptor protein activates EGFR and MAPK/ERK signaling.
Non-receptor tyrosine kinases involve many well-defined proteins (e.g. the Src family kinases, c-Abl, and Jak kinases) and other kinases which regulates cell growth and differentiation. For example, Src family kinases are curial for activating and inhibitory pathways in the innate immune response.
-
A3544 LDK378 dihydrochlorideSummary: ALK inhibitor
-
A3545 LDN193189 Hydrochloride1 CitationSummary: ALK inhibitor,potent and selective
-
A3155 ALK inhibitor 2Summary: ALK inhibitor, novel and selective
-
A3193 ASP3026Summary: ALK inhibitor,potent and selective
-
A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: IGF-IR/IR/ALK inhibitor, ATP-competitive
-
A8393 CH5424802Target: ALKSummary: ALK inhibitor,potent and ATP-competitive
-
A8620 AZD-34633 CitationTarget: ALK|Insulin-like growth factors (IGFs)Summary: ALK/IGF1R inhibitor
-
A3020 (R)-Crizotinib2 CitationTarget: c-METSummary: C-MET/ALK inhibitor,potent and ATP-competitve
-
A8251 TAE684 (NVP-TAE684)Summary: ALK inhibitor,potent and selective
-
A5602 SB525334Summary: (TGF-beta1) receptor inhibitor